• Veratridine: A Voltage-Gated Sodium Channel Opener

  2026-08-15

  Veratridine converts sodium-channel activation into a controlled experimental stress, enabling mechanistic neurophysiology, excitotoxicity studies, and blocker-screening workflows. Its persistent depolarization also supports carefully bounded translational experiments, provided acute channel effects are separated from downstream cell injury.

• PEI Transfection as a Bridge to Cuproptosis Research

  2026-08-14

  A translational framework for using Polyethylenimine Linear (PEI), MW 40,000 to validate lncRNA biology, improve experimental rigor, and connect transient gene expression with emerging cuproptosis research in breast cancer.

• Phillygenin and Signaling in Diabetic Nephropathy

  2026-08-14

  The reference study shows that phillygenin protects against diabetic nephropathy by suppressing TLR4/MyD88/NF-κB-driven inflammation while strengthening PI3K/AKT/GSK3β-associated survival signaling. By combining RNA sequencing, podocyte experiments, biochemical assays, and db/db mouse validation, the work connects pathway modulation with reduced apoptosis, podocyte injury, and albuminuria.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-08-13

  Navazesh and Ji used IPEC-J2 enterocytes to show that iron deficiency and iron excess produce distinct transcriptional and metabolic adaptations. Their combined iron perturbation, inflammatory stimulation, gene-expression analysis, and untargeted metabolomics framework links iron availability to epithelial proliferation, energy metabolism, antioxidant status, and inflammatory signaling.

• Acifran and the Next Wave of HCAR2/HCAR3 Research

  2026-08-13

  Acifran is more than a receptor agonist in a catalog: it is a structurally resolved probe for connecting HCAR2/HCAR3 activation with lipid metabolism and translational assay design. This article interprets recent cryo-EM evidence, defines practical validation strategies, and shows how Acifran can support more discriminating metabolic disorder research.

• HotStart Universal 2X FAST Green qPCR Master Mix Guide

  2026-08-12

  HotStart Universal 2X FAST Green qPCR Master Mix combines rapid amplification, hot-start specificity, inhibitor tolerance, and a universal ROX reference dye for reproducible gene expression analysis. This workflow shows how to apply it when validating AKTIP and other candidate biomarkers from computational cancer studies.

• Wnt-C59 Workflows for PORCN Inhibition

  2026-08-12

  Wnt-C59 provides a precise way to test how PORCN-dependent Wnt secretion shapes reporter activity, cancer-cell behavior, and exosome-mediated osteogenesis. This practical guide connects dose planning, Wnt/β-catenin readouts, cholangiocarcinoma assays, and the lithium–Wnt10a reference study without treating a research inhibitor as a clinical therapy.

• Hydroxychloroquine Sulfate: Workflow Guide

  2026-08-11

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible perturbation for short-term studies of autophagy pathway modulation and TLR7/9 signaling in autoimmune disease research. Use water-based preparation and fresh solutions; avoid DMSO, ethanol, and protocols requiring long-term solution storage.

• EDC.HCl: Practical Coupling Workflow Guide

  2026-08-11

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for controlled amide bond formation with primary amines in peptide, bioconjugation, and related in vitro workflows. It is intended for laboratory use only; the dossier reports no in vivo or clinical data, and solutions should not be stored long term.

• Acifran: HCAR2/HCAR3 Evidence Guide

  2026-08-10

  Acifran, also called (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid, is a research agonist for HCAR2/GPR109A and HCAR3/GPR109B. Cryo-EM structures place Acifran in both receptor–Gi complexes, supporting its use as a mechanistic probe for lipid signaling pathway modulation rather than as a diagnostic or medical product.

• In Vitro Cancer Drug Response Assays: Schwartz Dissertation

  2026-08-09

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measures capture different mixtures of proliferative arrest and cell death. The framework supports more precise interpretation of drug-response assays by incorporating response magnitude, mechanism, and timing into experimental design.

• Fumagillin in Azumiobodo hoyamushi Control

  2026-08-08

  Park and colleagues evaluated 20 compounds against Azumiobodo hoyamushi, the protozoan associated with soft tunic syndrome in cultured Halocynthia roretzi. Fumagillin showed moderate in vitro parasite-killing activity, while formalin and chlorine dioxide produced the clearest reductions in parasite burden in experimentally infected ascidians.

• Dual-Readout mRNA for Macrophage Delivery

  2026-08-07

  Macrophage gene delivery fails when uptake is mistaken for functional expression. This thought-leadership article explains how Cap1 chemistry, 5-moUTP, and covalently linked Cy5 create a dual-readout framework for optimizing nanoparticle delivery, translation, immune compatibility, and translational decision-making.

• Entinostat (MS-275): Redefining Cancer Drug Response Evaluat

  2026-08-07

  Discover how Entinostat (MS-275) advances cancer research as a selective HDAC inhibitor. This article reveals nuanced insights into drug response assessment and practical assay design, elevating your oncology workflows with evidence-driven guidance.

• NLRP10 Regulates Keratinocyte Survival and Skin Barrier in A

  2026-08-06

  The reference study uncovers the mechanistic role of NLRP10 in supporting keratinocyte survival and P63-mediated epidermal differentiation, directly linking reduced NLRP10 expression to impaired skin barrier function in atopic dermatitis. These findings clarify genetic associations and suggest NLRP10 as a promising therapeutic target for restoring epidermal homeostasis.

554 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page